Ads
related to: multiple myeloma- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Contact a Representative
For Questions and Information
About This Treatment
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Primary and Subgroup Data
Search results
Jerry W. Bryan
The Virginian-Pilot· 6 days agoJerry W. Bryan passed away peacefully at home on May 12, 2024, surrounded by his loving wife and children. After graduating from Cox High School, he enlisted in the US Army and served as a Paratrooper ...
Autolus Therapeutics (NASDAQ:AUTL) Shares Down 5.5% Following Weak Earnings
ETF DAILY NEWS· 1 day agoAutolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) dropped 5.5% during mid-day trading on Monday following a dissappointing earnings announcement. The stock traded as low as $4.14 and ...
Anna Marie Alleman
WKBT La Crosse· 6 days agoAnna Marie Alleman, 85 years old, lived in La Crosse, WI (formerly of Mindoro) with her two cats, “Skinny Sue” and “Charlie” too. Anna passed peacefully at her home on
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 2 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
ETF DAILY NEWS· 5 days agoStock analysts at StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on ...
7 cancer disparities to watch for in 2024
Becker’s Hospital Review· 6 days agoIn 2024, more than 2 million new cancer cases are projected to be diagnosed, and more than 611,700 deaths from cancer are expected, a May American Association of Cancer Research report found ...
Arcellx (NASDAQ:ACLX) Upgraded by Evercore ISI to Strong-Buy
ETF DAILY NEWS· 6 days agoEvercore ISI upgraded shares of Arcellx (NASDAQ:ACLX – Free Report) to a strong-buy rating in a research note published on Monday morning, Zacks.com reports. Robert W. Baird boosted their price ...
Autolus Therapeutics (NASDAQ:AUTL) Releases Earnings Results, Misses Expectations By $0.14 EPS
ETF DAILY NEWS· 2 days agoAutolus Therapeutics (NASDAQ:AUTL – Get Free Report) posted its earnings results on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus ...
Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Sold by National Bank of Canada FI
ETF DAILY NEWS· 2 days agoNational Bank of Canada FI reduced its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 41.7% during the 4th quarter, according to its most recent 13F filing with ...
Needham & Company LLC Reaffirms Buy Rating for Autolus Therapeutics (NASDAQ:AUTL)
ETF DAILY NEWS· 2 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Friday, Benzinga reports. They currently have a ...
Ad
related to: multiple myeloma